Pluri Inc. (PLUR)
PLUR Stock Price Chart
Explore Pluri Inc. interactive price chart. Choose custom timeframes to analyze PLUR price movements and trends.
PLUR Company Profile
Discover essential business fundamentals and corporate details for Pluri Inc. (PLUR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Jun 2003
Employees
106.00
Website
https://pluri-biotech.comCEO
Yaacov Yanay
Description
Pluri Inc., a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range of inflammatory conditions, muscle injuries, and hematological disorders. The company's therapeutic pipeline centers on placental expanded (PLX) cell technology. A key candidate, PLX-PAD, is in advanced clinical development, with ongoing Phase III trials for muscle recovery after hip fracture surgery, Phase II studies for acute respiratory distress syndrome associated with COVID-19, and Phase I/II trials for steroid-refractory Graft-versus-Host Disease. Additionally, Pluri is advancing PLX-R18, a treatment designed to aid in incomplete hematopoietic recovery following hematopoietic cell transplantation and to address acute radiation syndrome. The company rebranded to Pluri Inc. in July 2022, having previously operated as Pluristem Therapeutics Inc.
PLUR Financial Timeline
Browse a chronological timeline of Pluri Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Sept 2026
EPS estimate is -$0.66, while revenue estimate is $655.00k.
Earnings released on 14 May 2026
EPS came in at -$0.55 surpassing the estimated -$0.66 by +16.67%, while revenue for the quarter reached $167.00k , missing expectations by -74.50%.
Earnings released on 12 Feb 2026
EPS came in at -$0.71 falling short of the estimated -$0.65 by -9.23%, while revenue for the quarter reached $198.00k , missing expectations by -68.97%.
Earnings released on 12 Nov 2025
EPS came in at -$0.65 surpassing the estimated -$0.74 by +12.16%, while revenue for the quarter reached $316.00k , missing expectations by -50.47%.
Earnings released on 17 Sept 2025
EPS came in at -$2.62 falling short of the estimated -$0.65 by -303.08%, while revenue for the quarter reached $398.00k , missing expectations by -37.62%.
Earnings released on 13 May 2025
EPS came in at -$0.94 falling short of the estimated -$0.73 by -28.77%, while revenue for the quarter reached $427.00k , beating expectations by +6.75%.
Earnings released on 11 Feb 2025
EPS came in at -$0.53 , while revenue for the quarter reached $185.00k .
Earnings released on 12 Nov 2024
EPS came in at -$1.08 , while revenue for the quarter reached $326.00k , missing expectations by -99.59%.
Earnings released on 18 Sept 2024
EPS came in at -$2.98 falling short of the estimated $0.16 by -1.96k%, while revenue for the quarter reached $96.00k , missing expectations by -99.34%.
Earnings released on 9 May 2024
EPS came in at -$1.01 falling short of the estimated -$0.24 by -320.83%, while revenue for the quarter reached $71.00k , missing expectations by -99.38%.
Stock split effective on 1 Apr 2024
Shares were split 1 : 8 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Feb 2024
EPS came in at -$0.96 , while revenue for the quarter reached $105.00k .
Earnings released on 13 Nov 2023
EPS came in at -$0.96 , while revenue for the quarter reached $54.00k .
Earnings released on 12 Sept 2023
EPS came in at -$1.20 surpassing the estimated -$2.48 by +51.61%, while revenue for the quarter reached $111.00k .
Earnings released on 9 May 2023
EPS came in at -$1.52 surpassing the estimated -$2.40 by +36.67%, while revenue for the quarter reached $87.00k .
Earnings released on 13 Feb 2023
EPS came in at -$1.92 surpassing the estimated -$2.56 by +25.00%, while revenue for the quarter reached $2.00k .
Earnings released on 10 Nov 2022
EPS came in at -$1.52 falling short of the estimated -$0.32 by -375.00%, while revenue for the quarter reached $87.00k .
Earnings released on 21 Sept 2022
EPS came in at -$2.24 falling short of the estimated -$0.35 by -540.00%, while revenue for the quarter reached $234.00k .
Earnings released on 9 May 2022
EPS came in at -$0.31 surpassing the estimated -$0.36 by +13.89%, while revenue for the quarter reached $234.00k , missing expectations by -12.20%.
Earnings released on 7 Feb 2022
EPS came in at -$0.34 surpassing the estimated -$0.38 by +10.53%.
Earnings released on 8 Nov 2021
EPS came in at -$0.36 surpassing the estimated -$0.41 by +12.20%.
Earnings released on 13 Sept 2021
EPS came in at -$0.46 falling short of the estimated -$0.40 by -15.00%.
PLUR Stock Performance
Access detailed PLUR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
